Loading...
Market
What will be the primary application for reprogrammed astroglia in regenerative medicine by 2025?
2
Resolution / Starting Odds
Neurodegenerative diseases • 25%
Traumatic brain injuries • 25%
Psychiatric disorders • 25%
Other • 25%
Peer-reviewed publications or industry reports
Story
Reprogrammed Brain Cells Could Restore Damaged Circuits, Specific Interneurons
Nov 11, 2024, 04:15 PM
Researchers have successfully reprogrammed brain support cells called astroglia into neuron-like cells that mimic specific interneurons vital for brain functions. This study, focusing on regenerative medicine, could potentially restore damaged brain circuits. Additionally, new research shows that astrocytes, non-neuronal brain cells, help determine whether memories are stored long-term or forgotten. In mice, acidifying astrocytes shortly after a traumatic event led to the memory fading within a short period.
View original story
Similar markets
Age-related macular degeneration • 25%
Diabetic retinopathy • 25%
Retinitis pigmentosa • 25%
No other application • 25%
New drug approval • 25%
Major clinical trial success • 25%
New treatment guidelines • 25%
Other • 25%
Breast Cancer Diagnosis • 25%
Lung Cancer Diagnosis • 25%
Prostate Cancer Diagnosis • 25%
Other • 25%
Cancer treatment advancements • 25%
Rare disease understanding • 25%
Regenerative medicine • 25%
Other • 25%
Parkinson's Disease • 25%
Heart Disease • 25%
Spinal Cord Injury • 25%
Other • 25%
Neurodegenerative diseases • 25%
Psychiatric disorders • 25%
Neurological injury • 25%
Other • 25%
Early skin cancer detection • 25%
Blood flow monitoring • 25%
Digestive system observation • 25%
Other • 25%
Cancer research • 25%
Drug development • 25%
Genetic disease research • 25%
Other applications • 25%
Human gene editing • 25%
Animal models • 25%
Plant genomics • 25%
Microbial engineering • 25%
Successful Phase I trial • 25%
FDA Fast Track designation • 25%
Publication of promising preclinical results • 25%
No major milestone achieved • 25%
Speech restoration • 25%
Motor function restoration • 25%
Sensory restoration • 25%
Other • 25%